The awareness of the presence and consequences of sarcopenia has significantly
increased over the past decade. Sarcopenia is defined as gradual loss of muscle mass and …

Background Age-related loss of muscle, sarcopenia, is recognised as a clinical syndrome
with multiple contributing factors. International European Working Group on Sarcopenia in …

Background Sarcopenia was recently recognized as an independent condition by an
International Classification of Diseases, Tenth Revision, Clinical Modification code, and is a …

Sarcopenia prevalence and its clinical impact are reportedly variable in chronic obstructive
pulmonary disease (COPD) due partly to definition criteria. This review aimed to identify the …

Decreased physical performance due to loss of muscle mass (ie sarcopenia) is prevalent in
ageing and appears more pronounced in chronic disease. A comprehensive profile of the …

Sarcopenia is frequently associated with chronic diseases such as chronic obstructive
pulmonary disease (COPD) and cancer. COPD, which is characterized by an irreversible …

Chronic obstructive pulmonary disease (COPD) is a common pulmonary disease
characterized by persistent respiratory symptoms and airflow restriction, often accompanied …

Objectives Sarcopenia is common in chronic obstructive pulmonary disease (COPD) and
may contribute to increased cardiometabolic risk. Interventions to reduce cardiometabolic …

Chronic obstructive pulmonary disease (COPD) has been described as a systemic disease.
Sarcopenia is one of the systemic effects that is related to several adverse outcomes. The …

Abstract Background/Objectives Sarcopenia defined by the association of skeletal muscle
mass depletion and a decreased physical performance is underdiagnosed in chronic …